Omicron variant spike protein
GPTKB entity
Statements (43)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:protein
|
| gptkbp:affects |
vaccine efficacy
antibody neutralization |
| gptkbp:binds |
gptkb:ACE2_receptor
|
| gptkbp:domain |
gptkb:heptad_repeat_1
gptkb:heptad_repeat_2 transmembrane domain fusion peptide cytoplasmic tail N-terminal domain receptor binding domain |
| gptkbp:enables |
cell entry
|
| gptkbp:encodedBy |
gptkb:S_gene
|
| gptkbp:foundIn |
gptkb:COVID-19
|
| gptkbp:hasAminoAcidLength |
1273
|
| gptkbp:hasGlycosylationSites |
22
|
| https://www.w3.org/2000/01/rdf-schema#label |
Omicron variant spike protein
|
| gptkbp:mutationAssociatedWith |
gptkb:D614G
gptkb:T478K gptkb:N501Y gptkb:E484A gptkb:N440K gptkb:Q493R gptkb:Q498R gptkb:S373P gptkb:Y505H K417N P681H G339D G446S S371L S375F |
| gptkbp:partOf |
gptkb:Omicron_variant
|
| gptkbp:studiedIn |
epidemiology
immunology virology |
| gptkbp:subunit |
S1
S2 |
| gptkbp:target |
gptkb:COVID-19_vaccines
neutralizing antibodies |
| gptkbp:wasFirstIdentified |
November 2021
|
| gptkbp:bfsParent |
gptkb:SARS-CoV-2_spike_protein
|
| gptkbp:bfsLayer |
6
|